Legal Representation
Attorney
David S. Jacobson
USPTO Deadlines
Next Deadline
1122 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230214)
Due Date
February 14, 2029
Grace Period Ends
August 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 14, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 14, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 10, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 9, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jan 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 31, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 29, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 31, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 29, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 29, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 29, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 14, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 29, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 14, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 29, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 9, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 9, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 9, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 9, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 9, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 9, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 9, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 24, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 22, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 22, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 22, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 29, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 4, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 4, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 14, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 1, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 5, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 13, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test strips for use in the field of infectious diseases
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Additional Information
Pseudo Mark
DPP SARS-COV-TWO IGG/IGM
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SARS-COV-2 IGG/IGM"